series-b
Stage
2020
Founded
1
Investors
About
SciNeuro Pharmaceuticals develops innovative therapies for central nervous system (CNS) diseases, focusing on neurodegenerative conditions like Alzheimer's and Parkinson's. The company employs a proprietary blood-brain barrier shuttle platform to deliver therapeutic molecules to the brain.
Explore SciNeuro's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.